NORBERT G RIEDEL Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for NORBERT G RIEDEL.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of NORBERT G RIEDEL. NORBERT G RIEDEL is a Corporate Vice President in BAXTER INTERNATIONAL INC ($BAX) and a Senior Vice President in BAXTER INTERNATIONAL INC ($BAX) and a Director in ARIAD PHARMACEUTICALS INC ($ARIA) and a Director in Jazz Pharmaceuticals plc ($JAZZ) and a CEO in Aptinyx Inc. ($APTX) and a CEO and President in Aptinyx Inc. ($APTX) and a Director in Eton Pharmaceuticals, Inc. ($ETON) and a Director in Cerevel Therapeutics Holdings, Inc. ($ARYB).
Address: ONE BAXTER PARKWAY DEERFIELD 60015 IL
Companies in which NORBERT G RIEDEL is an Insider
Aptinyx Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of NORBERT G RIEDEL: CEO and President
Holdings: 35,000 shares
Latest Transaction: Feb 26 2021
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
ARIAD PHARMACEUTICALS INC
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of NORBERT G RIEDEL: Director
Holdings: 0 shares
Current Value: $0
Latest Transaction: Feb 16 2017
$ARIA Market Capitalization: $4.64B
$ARIA Previous Close: $23.81
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
BAXTER INTERNATIONAL INC
Industry: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
Position of NORBERT G RIEDEL: Corporate Vice President, Senior Vice President
Holdings: 56,689 shares
Current Value: $2,754,519
Latest Transaction: Jan 18 2013
$BAX Market Capitalization: $26.30B
$BAX Previous Close: $48.59
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Cerevel Therapeutics Holdings, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of NORBERT G RIEDEL: Director
Holdings: 28,540 shares
Latest Transaction: Jan 06 2021
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Eton Pharmaceuticals, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of NORBERT G RIEDEL: Director
Holdings: 59,745 shares
Latest Transaction: Mar 16 2020
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Jazz Pharmaceuticals plc
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of NORBERT G RIEDEL: Director
Holdings: 10,390 shares
Current Value: $1,299,270
Latest Transaction: Aug 10 2020
$JAZZ Market Capitalization: $7.62B
$JAZZ Previous Close: $125.05
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of NORBERT G RIEDEL
Sentiment: All, APTX, ARIA, BAX, CERE, ETON, JAZZ
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 26 2021 | APTX | Aptinyx Inc. | RIEDEL NORBERT G | CEO | Option Exercise | A | 3.80 | 733,300 | 2,786,540 | 733,300 | |
| Jan 06 2021 | ARYB | Cerevel Therapeuti ... | RIEDEL NORBERT G | Director | Option Exercise | M | 0.00 | 14,270 | 0 | 14,270 | |
| Jan 06 2021 | ARYB | Cerevel Therapeuti ... | RIEDEL NORBERT G | Director | Buy | M | 0.00 | 14,270 | 0 | 28,540 | 14.3 K to 28.5 K (+100.00 %) |
| Aug 10 2020 | JAZZ | Jazz Pharmaceutica ... | RIEDEL NORBERT G | Director | Option Exercise | A | 127.07 | 6,765 | 859,629 | 6,765 | |
| Aug 10 2020 | JAZZ | Jazz Pharmaceutica ... | RIEDEL NORBERT G | Director | Sell | S | 125.87 | 931 | 117,186 | 9,459 | 10.4 K to 9.5 K (-8.96 %) |
| Aug 10 2020 | JAZZ | Jazz Pharmaceutica ... | RIEDEL NORBERT G | Director | Grant | A | 0.00 | 2,705 | 0 | 10,390 | 7.7 K to 10.4 K (+35.20 %) |
| Mar 16 2020 | ETON | Eton Pharmaceutica ... | RIEDEL NORBERT G | Director | Option Exercise | A | 3.58 | 27,400 | 98,092 | 27,400 |